All content © Simona Rapposelli

Designed by Massimiliano Runfola

Patents

10. Sestito S, Daniele S, Martini C, Rapposelli S, Puricelli G. 2-oxo-1,2-dihydropyridine-3-carboxamide compounds and their use as inhibitors of PDK1 July 2018

Patent n°: US2018155320 (A1)

9. Grassi F, Lisignoli G, Rapposelli S, Vincenzo V. New molecules for bone tissue regeneration December 2017

Patent n°: BR112017009613 (A2)

8. Sestito S, Daniele S, Martini C, Rapposelli S. 2-oxo-1,2-dihydropyridine-3-carboxamide compounds and their use as dual inhibitors of PDK1/AurA  December 2017

Patent n°: WO2017211946 (A1)

7. Rapposelli S, Martini C, Calderone V, Puricelli G. Pharmaceutical combination for the treatment of tumors. August 2017

Patent n°: EP3204002 (A1)

6. Chiellini G, Rapposelli S, Zucchi R. Synthetic analogues of 3-iodothyronamine (T1AM) and uses thereof. October 2015

Patent n°: WO2015151068A1

5. Pi R, Yang X, Rapposelli S, Chen Z, Wang S, Chu J, Tu Y, Liu P, Digiacomo M, Macchia M. Dimer of rivastigmine and caffeic acid or ferulic acid, preparation method and drug composition thereof  August 2015

Patent n°: CN104860847

4. Berardi F, Colabufo N A, Perrone R, Balsamo A, Rapposelli S, Digiacomo M. 1-phenylalkoxy-2-β-phenylethyl derivatives as P-Glycoprotein (P-GP) inhibitors useful in drug resistance eventsApril 2009

Patent n°: US20090093493A1

3. Balsamo A, Calderone V, Rapposelli S, Marchetti P, Torri S. Pharmacodynamic hybrids endowed of hypoglycemic and NO-donor activities obtained combining hydroxylated derivatives of Glibenclamide and nitrooxy-substituted carboxylic acids  February 2008

Patent n°: ITPI20060103 (A1)

2. Balsamo A, Calderone V, Rapposelli SNitrogenous N-substituted 4-spiro-heterocyclic 2, 2-dimethylchromane derivatives January 2008

Patent n°: ITPI20060083 (A1)

1. Balsamo A, Berardi F, Colabufo N A, Perrone R, Rapposelli S. 1-fenilalcossi-2-B-feniletilderivati quali inibitori della glicoproteina P (GP-P) utilizzabili in casi di farmacoresistenza October 2007

Patent n°: IT2006RM0217A1